✦ LIBER ✦

PND26 COST-UTILITY OF INTERFERON BETA-1B IN THE TREATMENT OF PATIENTS WITH A CLINICALLY ISOLATED SYNDROME SUGGESTIVE OF MULTIPLE SCLEROSIS IN SPAIN

✍ Scribed by T Arbizu; C Piñol; V Casado

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PND15 COST-UTILITY OF INTERFERON BETA-1B

✍ JP Caloyeras; C Wang; L Bauer; WC Lee; V Lanius; K Gondek 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

ND4 COST-UTILITY OF INTERFERON BETA-1B I

✍ JP Caloyeras; B Harrow; C Wang; K Beckmann; V Knappertz; C Pohl; JD Miller; MW R 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

Cost-Effectiveness Analysis of Interfero

✍ John P. Caloyeras; Bin Zhang; Cheng Wang; Marianne Eriksson; Sten Fredrikson; Ka 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 882 KB

PND6 COMPARISON OF COSTS FOR INTERFERON

✍ C Kozma; M Dickson; DM Meletiche 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

Good results for early treatment of clin

✍ Doggrell, Sheila A 📂 Article 📅 2010 🏛 Informa plc 🌐 English ⚖ 207 KB

The effect of interferon-beta1a on relap

✍ Mohammad Reza Motamed; Neda Najimi; Seyed-Mohammad Fereshtehnejad 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 210 KB